<DOC>
	<DOC>NCT00767637</DOC>
	<brief_summary>To measure lanthanum concentrations in bone in patients with hyperphosphatemia receiving dialysis</brief_summary>
	<brief_title>Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone</brief_title>
	<detailed_description />
	<mesh_term>Hyperphosphatemia</mesh_term>
	<criteria>Patients undergoing dialysis or plan to start dialysis before the initial administration of the study medication Patients with severe hypocalcemia (adjusted serum calcium level of &lt;7.5 mg/dL)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>